David Turkaly
Stock Analyst at Citizens
(2.30)
# 2,657
Out of 5,131 analysts
144
Total ratings
43.94%
Success rate
-2.18%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Upgrades: Market Outperform | $440 | $367.54 | +19.71% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $1.10 | +356.62% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.49 | +129.23% | 6 | Nov 12, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $26 → $34 | $33.51 | +1.46% | 8 | Oct 30, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $18.31 | +36.54% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $67.56 | +8.05% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $15.78 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $94.47 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $82.03 | +21.91% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $256.82 | +9.03% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $13.58 | +84.09% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $29.68 | +85.31% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $92.85 | +34.63% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $470.61 | +6.25% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $112.81 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $20.44 | +56.56% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.21 | +94.88% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $2.07 | +44.93% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.57 | -47.75% | 1 | Oct 6, 2017 |
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $367.54
Upside: +19.71%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $1.10
Upside: +356.62%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.49
Upside: +129.23%
Axogen
Oct 30, 2025
Maintains: Market Outperform
Price Target: $26 → $34
Current: $33.51
Upside: +1.46%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $18.31
Upside: +36.54%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $67.56
Upside: +8.05%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $15.78
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $94.47
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $82.03
Upside: +21.91%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $256.82
Upside: +9.03%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $13.58
Upside: +84.09%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $29.68
Upside: +85.31%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $92.85
Upside: +34.63%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $470.61
Upside: +6.25%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $112.81
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $20.44
Upside: +56.56%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.21
Upside: +94.88%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $2.07
Upside: +44.93%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.57
Upside: -47.75%